Teysir, Jimmitti http://orcid.org/0000-0003-1334-0701
Gegechkori, Nana
Wisnivesky, Juan P.
Lin, Jenny J.
Funding for this research was provided by:
National Cancer Institute Cancer Prevention and Control Career Development Award (1K07CA166462)
Article History
Received: 25 March 2019
Accepted: 20 April 2019
First Online: 26 April 2019
Change Date: 5 June 2019
Change Type: Correction
Change Details: In the original publication of the article, under the Methods section, second paragraph, the sentence that reads as “We excluded 3047 patients … surgical treatment (see Fig. 1)” should read as “We excluded 3047 patients who did not identify as black or white, 5395 who were not initially diagnosed with stage 0–III cancer or were missing stage or residence data, 2573 patients who passed away within 18 months of diagnosis, and 4716 patients who did not undergo primary surgical treatment (see Fig. 1)”.
Compliance with ethical standards
:
: Dr. Wisnivesky is a member of the research board of EHE International, has received consulting honorarium from Merck Pharmaceuticals and IMS Health, and a research grant from Aventis. All other authors are without any conflicts of interest.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: This study used de-identified data from the Surveillance, Epidemiology and End Results registry linked to Medicare claims (SEER-Medicare) and did not require informed consent to be obtained from this database.